Kiwi, do you agree for CABG patients, placebo arm could have a 4.3% event rate if JELIS used optimal statins like in R-I? With additional 2g EPA, you could knock the event rate further down to 4% or slightly below, right? That looks pretty good Vs 5.2% placebo group event rate in R-I. To conclude, your optimal statin hypothesis actually improves the odds of R-I success.
Market Data 
Markets 
AI
